STAT3 and cancer: From 2017 to 2022, the predominant focus of research on CAFs pertained to cancer treatment, with particular emphasis on STAT3, multidrug resistance, ionizing radiation (IR), and gold nanoparticles (GNPs) emerging as prominent areas of investigation.